About this trial
The goal of this clinical trial is to test a new online program called UPDOs Protective Styles to help people in the southeastern United States learn about and start using PrEP (pre-exposure prophylaxis), a medicine that helps prevent HIV. The study focuses on people who may be at higher risk for HIV and have not had equal access to PrEP.
The main questions it aims to answer are:
Does UPDOs help more people trust and understand PrEP? Does UPDOs increase the number of people who start and continue using PrEP?
Researchers will compare two groups:
One group will use UPDOs, which includes six weekly videos, blog discussions, and access to telehealth services through Q Care Plus. The other group will receive standard HIV prevention materials from the CDC.
Participants will:
Be recruited from 32 beauty salons in areas with high HIV rates. Complete surveys at the start of the study and again at 6, 12, 24, 32, and 52 weeks.
Have access to HIV testing and PrEP prescriptions through Q Care Plus.
This study will also look at how well the program works in different communities and how easy it is to use and share.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Black
cisgender female
Ages 18+
Disqualifiers
Under 18 years of age
Does not identify as Black
Not a cisgender female
Trial design
Parallel
Treatments tested in this trial
Using PrEP, Doing it for Ourselves (UPDOs)
BehavioralAn e-Health intervention that considers women's lived experiences and uses three components: beauty salons and stylists as opinion leaders (trusted gatekeepers who share health information in the community), theory driven edutainment videos and blogs, and a secure online platform for accessing pre-exposure prophylaxis (PrEP).
Standard of Care
Other interventionCDC standard of care, e.g., CDC videos and website.
Treatment groups
Trial outcomes
Primary outcomes
Pre-exposure prophylaxis (PrEP) Contemplation Ladder total score
The PrEP Contemplation Ladder is a 1-item survey designed to measure Motivational PrEP Cascade (MPC) stages of behavior change that represent one's PrEP intentions by a score of 1-10. Scores correspond to MPC stages. Lower numbers indicate PrEP is not being used to prevent HIV and the participant is not really thinking of ever starting to use PrEP. Higher numbers indicate that PrEP is being used daily and the participant is returning for provider checkups and HIV/STI testing every 3 months, as recommended.
Secondary outcomes
Change in pre-exposure prophylaxis (PrEP) Contemplation Ladder total score - 12 to 24 weeks
The PrEP Contemplation Ladder is a 1-item survey designed to measure Motivational PrEP Cascade (MPC) stages of behavior change that represent one's PrEP intentions by a score of 1-10. Scores correspond to MPC stages. Lower numbers indicate PrEP is not being used to prevent HIV and the participant is not really thinking of ever starting to use PrEP. Higher numbers indicate that PrEP is being used daily and the participant is returning for provider checkups and HIV/STI testing every 3 months, as recommended.
Change in pre-exposure prophylaxis (PrEP) Contemplation Ladder total score - 24 to 32 weeks
The PrEP Contemplation Ladder is a 1-item survey designed to measure Motivational PrEP Cascade (MPC) stages of behavior change that represent one's PrEP intentions by a score of 1-10. Scores correspond to MPC stages. Lower numbers indicate PrEP is not being used to prevent HIV and the participant is not really thinking of ever starting to use PrEP. Higher numbers indicate that PrEP is being used daily and the participant is returning for provider checkups and HIV/STI testing every 3 months, as recommended.
Change in pre-exposure prophylaxis (PrEP) Contemplation Ladder total score - 32 to 52 weeks
The PrEP Contemplation Ladder is a 1-item survey designed to measure Motivational PrEP Cascade (MPC) stages of behavior change that represent one's PrEP intentions by a score of 1-10. Scores correspond to MPC stages. Lower numbers indicate PrEP is not being used to prevent HIV and the participant is not really thinking of ever starting to use PrEP. Higher numbers indicate that PrEP is being used daily and the participant is returning for provider checkups and HIV/STI testing every 3 months, as recommended.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Duke University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Institute of Nursing Research (NINR)
Collaborator